Literature DB >> 8883252

Successful coronary artery bypass grafting for a patient with myelodysplastic syndrome: report of a case.

T Yamagishi1, K Fuse, T Saito, M Kato, Y Misawa, O Kamisawa, N Hasegawa, T Kawashima.   

Abstract

We report herein the case of a 61-year-old man with myelodysplastic syndrome causing pancytopenia who underwent successful coronary artery bypass grafting (CABG). Preoperatively, his hemoglobin (Hb) value was 10.4 g/dl while receiving transfusions of 1 or 2 units of red blood cells (RBC) every 2 weeks, his white blood cell (WBC) count was 8200/microliter with injections of 100 micrograms granulocyte colony-stimulating factor (G-SCF) every 5 days, and his platelet count was 4.5 x 10(4)/ microliter without platelet transfusion. From the time the pancytopenia was diagnosed in his peripheral blood, he had received a total of 104 units of RBC and 472 units of platelets, following which he developed an antiplatelet antibody, not for a platelet-specific antigen, but for an HLA antigen. Thus, HLA-matched platelets were prepared to prevent bleeding caused by thrombocytopenia, and the WBC count was elevated preoperatively by G-CSF injections. Thereafter, CABG was performed on three vessels. The HLA-matched platelets were transfused as the patient was weaned from the extracorporeal circulation. As a result of these preparations, we were able to protect the patient against bleeding and infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883252     DOI: 10.1007/bf00312098

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis.

Authors:  G T Williams; C A Smith; E Spooncer; T M Dexter; D R Taylor
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

2.  A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion.

Authors:  H Ikeda; T Mitani; M Ohnuma; H Haga; S Ohtzuka; T Kato; T Nakase; S Sekiguchi
Journal:  Vox Sang       Date:  1989       Impact factor: 2.144

3.  Platelet transfusion therapy; the selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing.

Authors:  R A Yankee; F C Grumet; G N Rogentine
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

4.  Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass.

Authors:  J M Porter; D Silver
Journal:  J Thorac Cardiovasc Surg       Date:  1968-12       Impact factor: 5.209

5.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

6.  Alloimmunization following platelet transfusion: the absence of a dose-response relationship.

Authors:  J P Dutcher; C A Schiffer; J Aisner; P H Wiernik
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

7.  Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases.

Authors:  H G Klingemann; S Self; M Banaji; H J Deeg; K Doney; S J Slichter; E D Thomas; R Storb
Journal:  Br J Haematol       Date:  1987-05       Impact factor: 6.998

Review 8.  Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment.

Authors:  P Noël; L A Solberg
Journal:  Crit Rev Oncol Hematol       Date:  1992       Impact factor: 6.312

Review 9.  Clonality in myelodysplastic syndromes.

Authors:  I S Weimar; J H Bourhis; G C De Gast; W R Gerritsen
Journal:  Leuk Lymphoma       Date:  1994-04

10.  The natural history of alloimmunization to platelets.

Authors:  J E Howard; H A Perkins
Journal:  Transfusion       Date:  1978 Jul-Aug       Impact factor: 3.157

  10 in total
  4 in total

1.  Mycotic abdominal aortic aneurysm associated with myelodysplastic syndrome (MDS): report of a case.

Authors:  K Yamamoto; Y Maruyama; O Namura; J Hayashi; S Koyama
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  Successful replacement of aortic root with valve-sparing technique and proximal arch in a patient with myelodysplastic syndrome.

Authors:  Tomomi Hasegawa; Takuro Tsukube; Tomonori Higuma; Yutaka Okita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-07

3.  Successful aortic valve replacement in severe pancytopenia related to myelodysplastic syndrome.

Authors:  Kazuhiro Kurisu; Yoshie Ochiai; Takashi Kajiwara; Ryuji Tominaga
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-02

4.  Minimally invasive mitral valve repair via right mini-thoracotomy in patient with myelodysplastic syndrome.

Authors:  Takura Taguchi; Hiroyuki Nishi; Kimihiro Kurose; Kohei Horikawa; Go Kanazawa; Toshiki Takahashi
Journal:  J Cardiothorac Surg       Date:  2018-05-18       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.